Carlos Alban, Senior Vice President at ABBOTT LABORATORIES (ABT), sold 1,793 shares at $53.20 ($95K) on 2010-02-10, disclosed to the SEC on 2010-02-12.
Scheduled sale ($95k) by Senior Vice President under a pre-arranged 10b5-1 plan. Pre-set trade — not a discretionary signal on the stock.
Nothing distinguishes this filing.
| Filing → |
| ABBV | SELL | 2018-03-02 | $19.1M | — | Filing → |
| ABBV | SELL | 2017-06-15 | $3.2M | — | Filing → |
| ABBV | SELL | 2017-05-08 | $2.9M | — | Filing → |